Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Fertility and Sterility
|
April 5, 2001
Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)
D de Jong, N S Macklon, M J Eijkemans, et al.
Regulatory Peptides
|
October 20, 1993
Insulin-like growth factor binding protein-2, 28 kDa and 24 kDa insulin-like growth factor binding protein levels are decreased in fluid of dominant follicles, obtained from normal and polycystic ovaries
A G Schuller, D J Lindenbergh-Kortleve, T D Pache, et al.
Human Reproduction (Oxford, England)
|
June 24, 2010
Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization
H M Fatemi, J C Kasius, A Timmermans, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 12, 2002
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization
B C Fauser, D de Jong, F Olivennes, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1991
Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease
B C Fauser, T D Pache, S W Lamberts, et al.
Clinical Endocrinology
|
February 1, 1996
Normal human follicle development: an evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles
H J van Dessel, I Schipper, T D Pache, et al.
Human Reproduction (Oxford, England)
|
December 1, 1993
Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist
P F Donderwinkel, D C Schoot, T D Pache, et al.
The Journal of Biological Chemistry
|
March 25, 1989
Expression of biologically active human follitropin in Chinese hamster ovary cells
J L Keene, M M Matzuk, T Otani, et al.
Progress in Growth Factor Research
|
January 1, 1995
Circulating and ovarian IGF binding proteins: potential roles in normo-ovulatory cycles and in polycystic ovarian syndrome
L C Giudice, H J van Dessel, N A Cataldo, et al.
Human Reproduction (Oxford, England)
|
July 16, 2008
Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF
W Verpoest, B C Fauser, E Papanikolaou, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Fertility and Sterility
|
April 5, 2001
Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)
D de Jong, N S Macklon, M J Eijkemans, et al.
Regulatory Peptides
|
October 20, 1993
Insulin-like growth factor binding protein-2, 28 kDa and 24 kDa insulin-like growth factor binding protein levels are decreased in fluid of dominant follicles, obtained from normal and polycystic ovaries
A G Schuller, D J Lindenbergh-Kortleve, T D Pache, et al.
Human Reproduction (Oxford, England)
|
June 24, 2010
Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization
H M Fatemi, J C Kasius, A Timmermans, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 12, 2002
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization
B C Fauser, D de Jong, F Olivennes, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1991
Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease
B C Fauser, T D Pache, S W Lamberts, et al.
Clinical Endocrinology
|
February 1, 1996
Normal human follicle development: an evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles
H J van Dessel, I Schipper, T D Pache, et al.
Human Reproduction (Oxford, England)
|
December 1, 1993
Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist
P F Donderwinkel, D C Schoot, T D Pache, et al.
The Journal of Biological Chemistry
|
March 25, 1989
Expression of biologically active human follitropin in Chinese hamster ovary cells
J L Keene, M M Matzuk, T Otani, et al.
Progress in Growth Factor Research
|
January 1, 1995
Circulating and ovarian IGF binding proteins: potential roles in normo-ovulatory cycles and in polycystic ovarian syndrome
L C Giudice, H J van Dessel, N A Cataldo, et al.
Human Reproduction (Oxford, England)
|
July 16, 2008
Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF
W Verpoest, B C Fauser, E Papanikolaou, et al.
Page
of 13